A considerably higher dose of the anti-tuberculosis drug rifampicin is safe and can also lead to a shorter treatment for tuberculosis and less resistance. This is […]
There are two simultaneously occurring pandemics in the U.S.: Racism and COVID-19. “These mutualistic pandemics have thrown into stark focus the separate and unequal systems through […]
(HealthDay)—Ambulatory disability and older age are associated with worse clinical severity of COVID-19, including death, among patients with multiple sclerosis (MS), according to a study published […]